Nanoparticles for Delivering Amoxicillin to Treat H. Pylori
Author Information
Author(s): Saahil Arora, Sankalp Gupta, Raj K. Budhiraja, Ramji D. Narang
Primary Institution: Nanomedicine Research Centre, Department of Pharmaceutics, I.S.F. College of Pharmacy, Moga, Punjab, India
Hypothesis
Can chitosan-alginate nanoparticles improve the delivery of amoxicillin for the eradication of Helicobacter pylori?
Conclusion
The study successfully developed a novel mucopenetrating nanoparticle system that enhances the delivery of amoxicillin to treat H. pylori infections.
Supporting Evidence
- The optimized nanoparticles showed excellent mucopenetration and localization in gastric mucosa.
- Amoxicillin-loaded nanoparticles demonstrated reduced degradation in simulated gastric fluid.
- The study utilized a Box-Behnken design for optimizing the formulation variables.
- Mucoadhesion studies indicated a decrease in adhesion, enhancing penetration into the gastric mucosa.
- Fluorescent imaging confirmed the localization of nanoparticles in the gastric epithelial layers.
Takeaway
Scientists created tiny particles to help a medicine called amoxicillin reach a bad germ in the stomach better, which can help people feel better.
Methodology
The nanoparticles were prepared using a modified ionic gelation method and optimized using a Box-Behnken design.
Potential Biases
Potential bias in the selection of experimental conditions and the small sample size.
Limitations
The study was conducted on rat models, which may not fully represent human responses.
Participant Demographics
Healthy male Wistar rats, weighing 170-230 g.
Statistical Information
P-Value
<0.0001
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website